Aurora was once considered the leading lighting among canadian cannabis stocks. Perhaps after a trying 2021, it can regain some of its Luster in 2022 with a nice rise in its share price.
Producers and Retailers Serving A Market that’s Quite Limited, at the end of the day.
OFTEN CONSIST of Rather RESTRICTIVE Medical Marijuana-only Regimes (Although, to give it its its day, Aurora is comparatively strong in this segment).
ONCE in the Past Five Quarters.
At Least It’s in Good Company in the Red Ink-Soaked Great White North.
To write Home About – PARTICularly If Look at the More Consistent Profitability of Selected U.S. Players Like Trulieve Cannabis.
, taxes, depreciation, and amortization (eBitda) by the First Half of 2023.
There are several issues with this.
of a Great Many Canadian and U.S. Publicly Traded Companies.
)..
in U.S. Federal Law that would all all, or a sunden explosion inmedical marijuana leading elsewhere Abroad, are both pipe dreams for now.